Effectiveness of Buteyko Breathing Exercise in Children With Uncontrolled Asthma: A Single Blind, Randomized Controlled Trial
Trial Snapshot
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 74
- Locations
- 1
- Primary Endpoint
- Asthma control
Study Overview
Brief Summary
This randomized controlled trial study aimed to measure the effectiveness of the combination of 4-weeks Buteyko breathing exercises and pharmacological therapy compared with pharmacological therapy alone in children with uncontrolled asthma.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- Single (Outcomes Assessor)
Eligibility Criteria
- Ages
- 7 Years to 17 Years (Child)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Children aged 7-17 years
- •Uncontrolled or partially controlled asthma (GINA Symptom Control Tool score > 1)
- •Receive bronchodilator therapy, either oral or inhaler from a pediatrician.
- •Children and parents/care givers agree to participate in the study until the end, and parents/care givers sign the informed consent form.
- •Can understand instructions.
Exclusion Criteria
- •Have received Buteyko breathing exercises or other breathing exercises.
- •Have congenital heart disease, pneumonia, or other significant and uncontrolled health disorders.
- •Have severe physical disabilities or mental retardation that could potentially prevent the implementation of Buteyko breathing exercises.
- •Have contraindications for spirometry examination
Arms & Interventions
Buteyko
Buteyko breathing exercise plus pharmacological treatment
Intervention: Buteyko (Behavioral)
Buteyko
Buteyko breathing exercise plus pharmacological treatment
Intervention: Asthma reliever and controller (Drug)
Control
Pharmacological treatment
Intervention: Asthma reliever and controller (Drug)
Outcomes
Primary Outcomes
Asthma control
Time Frame: At enrollment and end of fourth-week
Level of asthma control measured by Asthma Control Questionnaire (ACQ) - Indonesian version. Minimum value 0, maximum value 6. Higher score means worse outcome.
Secondary Outcomes
- Asthma Quality of Life(At enrollment and end of fourth-week)
- Bronchodilator use(At end of fourth-week)
- FEV1(At enrollment and end of fourth-week)
- FVC(At enrollment and end of fourth-week)
- FEV1/FVC(At enrollment and end of fourth-week)
- PEFR(At enrollment and end of fourth-week)
- Control Pause(At enrollment and end of fourth-week)
Investigators
Ivan Sofian Wibowo
dr.
Indonesia University